Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Prenatal detection and characterization of a psu idic(8)(p23.3) which likely derived from nonallelic homologous recombination between two MYOM2-repeats.

Li YC, Chien SC, Setlur SR, Lin WD, Tsai FJ, Lin CC.

J Formos Med Assoc. 2015 Jan;114(1):81-7. doi: 10.1016/j.jfma.2011.05.015. Epub 2012 Mar 8.

PMID:
25618588
2.

Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.

Perets R, Wyant GA, Muto KW, Bijron JG, Poole BB, Chin KT, Chen JY, Ohman AW, Stepule CD, Kwak S, Karst AM, Hirsch MS, Setlur SR, Crum CP, Dinulescu DM, Drapkin R.

Cancer Cell. 2013 Dec 9;24(6):751-65. doi: 10.1016/j.ccr.2013.10.013.

3.

Tumor archaeology reveals that mutations love company.

Setlur SR, Lee C.

Cell. 2012 May 25;149(5):959-61. doi: 10.1016/j.cell.2012.05.010. No abstract available.

4.

Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.

Demichelis F, Setlur SR, Banerjee S, Chakravarty D, Chen JY, Chen CX, Huang J, Beltran H, Oldridge DA, Kitabayashi N, Stenzel B, Schaefer G, Horninger W, Bektic J, Chinnaiyan AM, Goldenberg S, Siddiqui J, Regan MM, Kearney M, Soong TD, Rickman DS, Elemento O, Wei JT, Scherr DS, Sanda MA, Bartsch G, Lee C, Klocker H, Rubin MA.

Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6686-91. doi: 10.1073/pnas.1117405109. Epub 2012 Apr 10.

5.

ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.

Rickman DS, Chen YB, Banerjee S, Pan Y, Yu J, Vuong T, Perner S, Lafargue CJ, Mertz KD, Setlur SR, Sircar K, Chinnaiyan AM, Bismar TA, Rubin MA, Demichelis F.

Neoplasia. 2010 Dec;12(12):1031-40.

6.

Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization.

Setlur SR, Ihm C, Tchinda J, Shams S, Werner L, Cho EK, Thompson C, Phillips K, Rassenti LZ, Kipps TJ, Neuberg D, Freedman AS, Lee C, Brown JR.

Br J Haematol. 2010 Nov;151(4):336-45. doi: 10.1111/j.1365-2141.2010.08341.x. Epub 2010 Aug 31.

7.

Molecular sampling of prostate cancer: a dilemma for predicting disease progression.

Sboner A, Demichelis F, Calza S, Pawitan Y, Setlur SR, Hoshida Y, Perner S, Adami HO, Fall K, Mucci LA, Kantoff PW, Stampfer M, Andersson SO, Varenhorst E, Johansson JE, Gerstein MB, Golub TR, Rubin MA, Andrén O.

BMC Med Genomics. 2010 Mar 16;3:8. doi: 10.1186/1755-8794-3-8.

8.

Optimizing copy number variation analysis using genome-wide short sequence oligonucleotide arrays.

Oldridge DA, Banerjee S, Setlur SR, Sboner A, Demichelis F.

Nucleic Acids Res. 2010 Jun;38(10):3275-86. doi: 10.1093/nar/gkq073. Epub 2010 Feb 15.

9.

The impact of human copy number variation on a new era of genetic testing.

Choy KW, Setlur SR, Lee C, Lau TK.

BJOG. 2010 Mar;117(4):391-8. doi: 10.1111/j.1471-0528.2009.02470.x. Epub 2010 Jan 26. Review.

PMID:
20105165
10.

Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.

Setlur SR, Chen CX, Hossain RR, Ha JS, Van Doren VE, Stenzel B, Steiner E, Oldridge D, Kitabayashi N, Banerjee S, Chen JY, Schäfer G, Horninger W, Lee C, Rubin MA, Klocker H, Demichelis F.

Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):229-39. doi: 10.1158/1055-9965.EPI-09-1018.

11.

Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer.

Setlur SR, Mertz KD, Rubin MA.

BJU Int. 2009 May;103(9):1293; author reply 1293. doi: 10.1111/j.1464-410X.2009.08582_3.x. No abstract available.

PMID:
19402829
12.

SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.

Rickman DS, Pflueger D, Moss B, VanDoren VE, Chen CX, de la Taille A, Kuefer R, Tewari AK, Setlur SR, Demichelis F, Rubin MA.

Cancer Res. 2009 Apr 1;69(7):2734-8. doi: 10.1158/0008-5472.CAN-08-4926. Epub 2009 Mar 17.

13.

Distinct genomic aberrations associated with ERG rearranged prostate cancer.

Demichelis F, Setlur SR, Beroukhim R, Perner S, Korbel JO, Lafargue CJ, Pflueger D, Pina C, Hofer MD, Sboner A, Svensson MA, Rickman DS, Urban A, Snyder M, Meyerson M, Lee C, Gerstein MB, Kuefer R, Rubin MA.

Genes Chromosomes Cancer. 2009 Apr;48(4):366-80. doi: 10.1002/gcc.20647.

14.

Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.

Setlur SR, Mertz KD, Hoshida Y, Demichelis F, Lupien M, Perner S, Sboner A, Pawitan Y, Andrén O, Johnson LA, Tang J, Adami HO, Calza S, Chinnaiyan AM, Rhodes D, Tomlins S, Fall K, Mucci LA, Kantoff PW, Stampfer MJ, Andersson SO, Varenhorst E, Johansson JE, Brown M, Golub TR, Rubin MA.

J Natl Cancer Inst. 2008 Jun 4;100(11):815-25. doi: 10.1093/jnci/djn150. Epub 2008 May 27.

15.

Detection of early prostate cancer using a hepsin-targeted imaging agent.

Kelly KA, Setlur SR, Ross R, Anbazhagan R, Waterman P, Rubin MA, Weissleder R.

Cancer Res. 2008 Apr 1;68(7):2286-91. doi: 10.1158/0008-5472.CAN-07-1349.

16.

Integrative microarray analysis of pathways dysregulated in metastatic prostate cancer.

Setlur SR, Royce TE, Sboner A, Mosquera JM, Demichelis F, Hofer MD, Mertz KD, Gerstein M, Rubin MA.

Cancer Res. 2007 Nov 1;67(21):10296-303.

17.

Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.

Mertz KD, Setlur SR, Dhanasekaran SM, Demichelis F, Perner S, Tomlins S, Tchinda J, Laxman B, Vessella RL, Beroukhim R, Lee C, Chinnaiyan AM, Rubin MA.

Neoplasia. 2007 Mar;9(3):200-6.

18.

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

Demichelis F, Fall K, Perner S, Andrén O, Schmidt F, Setlur SR, Hoshida Y, Mosquera JM, Pawitan Y, Lee C, Adami HO, Mucci LA, Kantoff PW, Andersson SO, Chinnaiyan AM, Johansson JE, Rubin MA.

Oncogene. 2007 Jul 5;26(31):4596-9. Epub 2007 Jan 22. Erratum in: Oncogene. 2007 Aug 16;26(38):5692.

PMID:
17237811
20.

Current thoughts on the role of the androgen receptor and prostate cancer progression.

Setlur SR, Rubin MA.

Adv Anat Pathol. 2005 Sep;12(5):265-70.

PMID:
16210922
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk